Tumefactive Multiple Sclerosis: diagnostic study considering the differential diagnosis from other brain lesions by Haritanti, Afroditi et al.
	 Tumefactive	Multiple	Sclerosis	(MS)	 65
IntroductIon
Multiple	 sclerosis	 is	 an	 inflammatory	demyelinating	
disorder	of	CNS,	that	may	appear	with	a	variety	of	dif-
ferent	 clinical	 presentations	 and	 laboratory	findings.	
Tumefactive	MS	is	a	type	of	MS	which	is	character-










hospital	 emergency	 department,	 with	 left	 hemipare-
sis	 and	 dysarthria.	 Two	 similar	 transitory	 episodes	
were	 also	 revealed	 in	 his	 medical	 history.	 Cerebro-
spinal	fluid	analysis	revealed	IgG	oligoclonal	bands,	
therefore	 indicating	 possible	MS.	The	MRI	 showed	





in	 the	 ER,	 with	 status	 epilepticus,	 right	 hemipare-
sis	 and	walk	 disorders.	The	Computed	Tomography	
(CT)	 scan	 only	 revealed	 the	 first	 lesion	 in	 the	 right	
hemisphere	(Figure	1c).	The	MRI	confirmed	a	second	
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Figure 1.	a.	Axial	T2-weighted	 image	revealed	a	mass	 in	
the	 right	 semioval	 centre	 with	mediocre	 edema.	 b.	Axial	
T1-weighted	 image	 showed	 important	 restriction	 of	 the	
damage.	c.	Axial	CT	image	showed	hypointense	lesion	left	
respectively	with	 the	 first	 lesion	 d.The	MRI	 confirmed	 a	











image	 and	 coronal	 contrastenhanced	T1-	weighted	 image	












































ological	 findings;	 reactive	 astrocytosis	with	 atypical	








diagnosis	 from	glioma11.	The	 third	 observation	 con-
cerns	the	progress	of	the	underlying	pathology	and	the	




ty	of	 the	final	diagnosis	 rather	 than	proceeding	with	
the	 treatment	 such	 as	operation	or	 irradiation	of	 the	
lesion.	In	addition,	in	case	of	demyelinating	disorders	
the	response	to	steroid	therapy	is	usually	satisfactory.	
The	 inflammatory	 demyelinating	 brain	 disorders	
often	 imitate	 intracranial	 masses.	 The	 tumefactive	
MS	 should	 be	mainly	 differentiated	 from	 tumors	 as	









first	 patient	was	 successfully	 treated	 conservatively,	
on	the	contrary	to	the	second	one	who	underwent	un-
necessary	 surgical	 operation.	 In	 the	 second	 case	 the	
correct	diagnosis	was	made	later	with	the	contribution	
of	MR	spectroscopy	and	the	patient	was	then	treated	








In	 the	differential	diagnosis	of	 tumefactive	brain	 le-
sions,	 the	 tumefactive	MS	should	always	be	consid-





ADC: Apparent Diffusion Coeficient




MRI: Magnetic Resonance Imaging
MS: multiple sclerosis
MTR: magnetization transfer 
NAA: N-acetylaspartate
rCBF: blood cerebral flow 
β, γ-Glx: glutamate/glutamine
Figure 5. a.	Axial	 T1-weighted	 post-contrast	 MR	 image	
shows	 a	 small	 ring-enhancing	 lesion	 in	 the	 genu	 of	 the	
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